Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges  Por  arte de portada

Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

De: Annenberg Center for Health Sciences
  • Resumen

  • An indolent subtype of non-Hodgkin lymphoma, follicular lymphoma is characterized by eventual relapse of disease and the need for multiple lines of therapy, adding to the significant disease burden experienced by patients. Novel targeted agents in the relapsed/refractory setting have afforded new treatment options, but important clinical challenges exist, including optimal treatment sequencing, therapy evaluation and patient selection, transitions of care requirements, as well as toxicity management.
    Annenberg Center for Health Sciences
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • Solving Practice Challenges in Community-Based Interprofessional Care Teams
    Dec 14 2023

    In this 1-hour, online activity, lymphoma expert Jeremy Abramson, MD, shares his experience navigating these challenges as part of an interprofessional, multidisciplinary care team.

    Más Menos
    50 m

Lo que los oyentes dicen sobre Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.